Assessment Followed by Home-based Hybrid Robot + FES Rehabilitation Post-stroke

Status: Recruiting
Location: See location...
Intervention Type: Combination product
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The investigators have developed a novel robot-guided stretching under intelligent control and combine it with active movement training, which helped increase joint ROM, reduce spasticity and joint stiffness, increase muscle force output, and improve locomotion. However, for stroke survivors with sensorimotor impairment, their peripheral muscle may not sufficiently be recruited. Functional electrical stimulation (FES), has been shown its advantage to activate the peripheral muscles for people with neurological conditions. The investigators thus make a hybrid robot-FES rehabilitation system, combining the advantage of robot and FES technologies for stroke motor recovery. The investigators further would like to translate the technologies from lab to home-based training. Thus, the investigators will conduct a randomized, controlled, primarily home-based clinical trial using an ankle robot alone or combined with functional electrical stimulation (FES) to treat sensorimotor and locomotion impairments post-stroke.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Age 18-85;

• Able to ambulate at least 10 meters without human assistance, with or without an assistive device

• ≥ 6 months post stroke;

• having a caregiver to assist in training at home.

Locations
United States
Maryland
University of Maryland School of Medicine
RECRUITING
Baltimore
Contact Information
Primary
Li-qun Zhang, PhD
L-Zhang@som.umaryland.edu
410 706 2145
Time Frame
Start Date: 2021-08-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 60
Treatments
Experimental: FES+robot
Participants in this group will have FES during ankle robot training
Active_comparator: Robot
Participants in this group will have ankle robot training only
Related Therapeutic Areas
Sponsors
Leads: University of Maryland, Baltimore

This content was sourced from clinicaltrials.gov